FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Vaccines (Basel) / Equids’ Core Vaccines Guidelines in North America: Con...
Vaccines2022; 10(3); doi: 10.3390/vaccines10030398

Equids’ Core Vaccines Guidelines in North America: Considerations and Prospective.

Abstract: Vaccination against infectious diseases is a cornerstone of veterinary medicine in the prevention of disease transmission, illness severity, and often death in animals. In North American equine medicine, equine vaccines protecting against tetanus, rabies, Eastern and Western equine encephalomyelitis, and West Nile are core vaccines as these have been classified as having a heightened risk of mortality, infectiousness, and endemic status. Some guidelines differ from the label of vaccines, to improve the protection of patients or to decrease the unnecessary administration to reduce potential side effects. In North America, resources for the equine practitioners are available on the American Association of Equine Practitioners (AAEP) website. Conversely, in small companion animals, peer review materials are regularly published in open access journals to guide the vaccination of dogs and cats. The aims of this review are to present how the vaccine guidelines have been established for small companion animals and horses in North America, to review the equine literature to solidify or contrast the current AAEP guidelines of core vaccines, and to suggest future research directions in the equine vaccine field considering small companion animal strategies and the current available resources in equine literature.
Get Full Text
Publication Date: 2022-03-04 PubMed ID: 35335029PubMed Central: PMC8955191DOI: 10.3390/vaccines10030398Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The article reviews the guidelines around core vaccines for horses in North America and discusses potential research directions, drawing upon strategies used in small companion animal vaccination.

Research Background

  • The research focuses on veterinary medicine, specifically vaccination against infectious diseases.
  • The main emphasis is on equine medicine, with core vaccines protecting against tetanus, rabies, Eastern and Western equine encephalomyelitis, and West Nile.
  • This is a preventive measure against diseases with high mortality rates, infectiousness, and endemic status.

Scope of the Research

  • The paper evaluates the guidelines concerning vaccines in North America.
  • It mentions that while some guidelines deviate from the vaccine labels to enhance protection or minimize unnecessary administration, the overall motive is to reduce potential side effects.
  • These guidelines and resources for equine practitioners are available on the American Association of Equine Practitioners (AAEP) website.
  • Among small companion animals like dogs and cats, peer-reviewed materials are openly published for guiding vaccination practices.

Aims and Objectives of the Research

  • The primary objectives of this research include offering insights into the establishment of vaccine guidelines for small companion animals and horses in North America.
  • It also reviews the current equine literature to validate or contrast the existing AAEP guidelines about core vaccines.
  • Lastly, the research aims to propose potential future research directions in the equine vaccine field, integrating strategies used for small companion animals and the resource availability as per current equine literature.

Cite This Article

APA
Desanti-Consoli H, Bouillon J, Chapuis RJJ. (2022). Equids’ Core Vaccines Guidelines in North America: Considerations and Prospective. Vaccines (Basel), 10(3). https://doi.org/10.3390/vaccines10030398

Publication

Vaccines
ISSN: 2076-393X
NlmUniqueID: 101629355
Country: Switzerland
Language: English
Volume: 10
Issue: 3

Researcher Affiliations

Desanti-Consoli, Hélène
  • DoctoraDesanti, San Jose 11801, Costa Rica.
Bouillon, Juliette
  • Department of Clinical Sciences, Ross University School of Veterinary Medicine, P.O. Box 334, Basseterre, Saint Kitts and Nevis.
Chapuis, Ronan J J
  • Department of Clinical Sciences, Ross University School of Veterinary Medicine, P.O. Box 334, Basseterre, Saint Kitts and Nevis.

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 84 references
  1. Aida V, Pliasas VC, Neasham PJ, North JF, McWhorter KL, Glover SR, Kyriakis CS. Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines. Front. Vet. Sci. 2021;8:340.
    doi: 10.3389/fvets.2021.654289pmc: PMC8083957pubmed: 33937377google scholar: lookup
  2. Cohen ND, Bordin AI. Principles of vaccination. John Wiley & Sons, Inc.; Chichester, UK: 2015; pp. 263–278.
  3. Wilson J. Vaccine efficacy and controversies. Proceedings of the 51st Annual Convention of the American Association of Equine Practitioners; Seattle, WA, USA. 3–7 December 2005; pp. 409–420.
  4. Barros T, Moran G, Uberti B. Reactive Seizures After Vaccination in a Thoroughbred Broodmare. J. Equine Vet. Sci. 2019;73:106–109.
    doi: 10.1016/j.jevs.2018.12.004google scholar: lookup
  5. American Association of Equine Practitioners (AAEP) Vaccination Guidelines. [(accessed on 26 December 2021)]. Available online: https://aaep.org/guidelines/vaccination-guidelines.
  6. Wilson W. Strategies for vaccinating mares, foals, and weanlings. Proceedings of the 51st Annual Convention of the American Association of Equine Practitioners; Seattle, WA, USA. 3–7 December 2005; pp. 421–438.
  7. Stone AE, Brummet GO, Carozza EM, Kass PH, Petersen EP, Sykes J, Westman ME. 2020 AAHA/AAFP feline vaccination guidelines. J. Am. Anim. Hosp. Assoc. 2020;56:249–265.
    doi: 10.5326/JAAHA-MS-7123pubmed: 0google scholar: lookup
  8. Ford RB, Larson LJ, McClure KD, Schultz RD, Welborn LV. 2017 AAHA canine vaccination guidelines. J. Am. Anim. Hosp. Assoc. 2017;53:243–251.
    doi: 10.5326/JAAHA-MS-6741pubmed: 28846453google scholar: lookup
  9. Bittle J, Grant W, Scott F. Canine and feline immunization guidelines—1982. J. Am. Vet. Med. Assoc. 1982;181:332–335.
    pubmed: 7118707
  10. Gumley N. Revaccination guidelines revisited. Can. Vet. J. 2000;41:26.
    pmc: PMC1476348pubmed: 10642869
  11. Klingborg DJ, Hustead DR, Curry-Galvin EA, Gumley NR, Henry SC, Bain FT, Paul MA, Boothe DM, Blood KS, Huxsoll DL. AVMA Council on Biologic and Therapeutic Agents’ report on cat and dog vaccines. J. Am. Vet. Med. Assoc. 2002;221:1401–1407.
    doi: 10.2460/javma.2002.221.1401pubmed: 12458607google scholar: lookup
  12. American Veterinary Medical Association Vaccination Principles. [(accessed on 26 December 2021)]. Available online: https://www.avma.org/resources-tools/avma-policies/vaccination-principles.
  13. Paul MA, Appel M, Barrett R, Carmichael LE. Report of the American Animal Hospital Association (AAHA) Canine Vaccine Task Force: Executive summary and 2003 canine vaccine guidelines and recommendations. J. Am. Anim. Hosp. Assoc. 2003;39:119.
    pubmed: 12617540
  14. Day MJ, Horzinek M, Schultz R, Squires R. WSAVA guidelines for the vaccination of dogs and cats. J. Small Anim. Pract. 2016;57:E1.
    doi: 10.1111/jsap.2_12431pmc: PMC7166872pubmed: 26780857google scholar: lookup
  15. American Animal Hospital Association (AAHA) Lifestyle-Based Vaccine Calculator. [(accessed on 26 December 2021)]. Available online: https://www.aaha.org/aaha-guidelines/2020-aahaaafp-feline-vaccination-guidelines/feline-vaccine-calculator/
  16. Wilson WD, Pusterla N, Long DC. Immunoprophylaxis. In: Sellon DC, Long MT, editors. Equine Infectious Diseases. 2nd ed. Elsevier Health Sciences; Saint Louis, MO, USA: 2013.
  17. Broaddus CC, Balasuriya UB, White JL, Timoney PJ, Funk RA, Holyoak GR. Evaluation of the safety of vaccinating mares against equine viral arteritis during mid or late gestation or during the immediate postpartum period. J. Am. Vet. Med. Assoc. 2011;238:741–750.
    doi: 10.2460/javma.238.6.741pubmed: 21401431google scholar: lookup
  18. Hooker B, Kern J, Geier D, Haley B, Sykes L, King P, Geier M. Methodological issues and evidence of malfeasance in research purporting to show Thimerosal in vaccines is safe. BioMed Res. Int. 2014;2014:247218.
    doi: 10.1155/2014/247218pmc: PMC4065774pubmed: 24995277google scholar: lookup
  19. Davis EG, Bello N, Bryan A, Hankins K, Wilkerson M. Characterisation of immune responses in healthy foals when a multivalent vaccine protocol was initiated at age 90 or 180 days. Equine Vet. J. 2015;47:667–674.
    doi: 10.1111/evj.12350pubmed: 25205445google scholar: lookup
  20. Pusterla N, Collier J, Mapes S, Wattanaphasak S, Gebhart C. Effects of administration of an avirulent live vaccine of Lawsonia intracellularis on mares and foals. Vet. Rec. 2009;164:783.
    doi: 10.1136/vr.164.25.783pubmed: 19542553google scholar: lookup
  21. Cauchard J, Sevin C, Ballet J-J, Taouji S. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine. Vet. Microbiol. 2004;104:73–81.
    doi: 10.1016/j.vetmic.2004.09.006pubmed: 15530741google scholar: lookup
  22. Martens R, Martens JG, Fiske R. Failure of passive immunisation by colostrum from immunised mares to protect foals against Rhodococcus equi pneumonia. Equine Vet. J. 1991;23:19–22.
    doi: 10.1111/j.2042-3306.1991.tb04752.xgoogle scholar: lookup
  23. Sturgill TL, Horohov DW. Vaccination response of young foals to keyhole limpet hemocyanin: Evidence of effective priming in the presence of maternal antibodies. J. Equine Vet. Sci. 2010;30:359–364.
    doi: 10.1016/j.jevs.2010.05.008google scholar: lookup
  24. Ryan C, Giguère S. Equine neonates have attenuated humoral and cell-mediated immune responses to a killed adjuvanted vaccine compared to adult horses. Clin. Vaccine Immunol. 2010;17:1896–1902.
    doi: 10.1128/CVI.00328-10pmc: PMC3008191pubmed: 20943883google scholar: lookup
  25. Wilson WD, Mihalyi J, Hussey S, Lunn D. Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination. Equine Vet. J. 2001;33:644–650.
    doi: 10.2746/042516401776249435pubmed: 11770984google scholar: lookup
  26. Cullinane A, Weld J, Osborne M, Nelly M, McBride C, Walsh C. Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings. Vet. J. 2001;161:174–185.
    doi: 10.1053/tvjl.2000.0546pubmed: 11243687google scholar: lookup
  27. Wilson WD. Vaccination programs for goals and weanlings. Proceedings of the 45th Annual Convention; Albuquerque, NM, USA. 5–8 December 1999; pp. 254–263.
  28. Muirhead T, McClure J, Wichtel J, Stryhn H, Markham R, McFarlane D, Lunn D. The effect of age on the immune response of horses to vaccination. J. Comp. Pathol. 2010;142:S85–S90.
    doi: 10.1016/j.jcpa.2009.10.010pubmed: 19954792google scholar: lookup
  29. Muirhead T, McClure J, Wichtel J, Stryhn H, Frederick Markham R, McFarlane D, Lunn D. The effect of age on serum antibody titers after rabies and influenza vaccination in healthy horses. J. Vet. Intern. Med. 2008;22:654–661.
    doi: 10.1111/j.1939-1676.2008.0091.xpubmed: 18466246google scholar: lookup
  30. McFarlane D. Equine pituitary pars intermedia dysfunction. Vet. Clin. Equine Pract. 2011;27:93–113.
    doi: 10.1016/j.cveq.2010.12.007pubmed: 21392656google scholar: lookup
  31. Recknagel S, Snyder A, Brueser B, Schusser GF. Immunization strategies and seroprotection against tetanus in horses in central Germany. Pferdeheilkunde 2015;31:469–476.
    doi: 10.21836/PEM20150506google scholar: lookup
  32. Kay G, Souhail M, Mazan M. Recurrent tetanus in a donkey. Equine Vet. Educ. 2021.
    doi: 10.1111/eve.13580google scholar: lookup
  33. Wilson WD. Assessment of Vaccination Status and Susceptibility to Infection. John Wiley & Sons; Hoboken, NJ, USA: 2017; p. 227.
  34. Kendall A, Anagrius K, Gånheim A, Rosanowski S, Bergström K. Duration of tetanus immunoglobulin G titres following basic immunisation of horses. Equine Vet. J. 2016;48:710–713.
    doi: 10.1111/evj.12502pubmed: 26284567google scholar: lookup
  35. Löhrer J, Radvila P. Active tetanus prophylaxis in the horse and the duration of immunity. Schweiz. Arch. Fur Tierheilkd. 1970;112:307–314.
    pubmed: 5516828
  36. Recknagel S, Snyder A, Blanke A, Uhlig A, Brüser B, Schusser GF. Evaluation of an immunochromatographic dipstick test for the assessment of tetanus immunity in horses. Berl. Und Munch. Tierarztl. Wochenschr. 2015;128:376–383.
    pubmed: 26591383
  37. Green SL, Little CB, Baird JD, Tremblay RR, Smith-Maxie LL. Tetanus in the horse: A review of 20 cases (1970 to 1990). J. Vet. Intern. Med. 1994;8:128–132.
    doi: 10.1111/j.1939-1676.1994.tb03210.xpubmed: 8046676google scholar: lookup
  38. Van Galen G, Saegerman C, Rijckaert J, Amory H, Armengou L, Bezdekova B, Durie I, Findshøj Delany R, Fouché N, Haley L. Retrospective evaluation of 155 adult equids and 21 foals with tetanus in Western, Northern, and Central Europe (2000–2014). Part 1: Description of history and clinical evolution. J. Vet. Emerg. Crit. Care. 2017;27:684–696.
    doi: 10.1111/vec.12668pubmed: 28960717google scholar: lookup
  39. Jansen B, Knoetze P. The Immune Response of Horses to Tetanus Toxoid. Onderstepoort J. Vet. Res. 1979;46:211–216.
    pubmed: 551370
  40. Heldens J, Pouwels H, Derks C, Van de Zande S, Hoeijmakers M. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix. Vaccine 2010;28:6989–6996.
    doi: 10.1016/j.vaccine.2010.08.043pubmed: 20728523google scholar: lookup
  41. Liefman C. Combined active-passive immunisation of horses against tetanus. Aust. Vet. J. 1980;56:119–122.
    doi: 10.1111/j.1751-0813.1980.tb05647.xpubmed: 7436904google scholar: lookup
  42. Harvey AM, Watson JL, Brault SA, Edman JM, Moore SM, Kass PH, Wilson WD. Duration of serum antibody response to rabies vaccination in horses. J. Am. Vet. Med. Assoc. 2016;249:411–418.
    doi: 10.2460/javma.249.4.411pubmed: 27479286google scholar: lookup
  43. National Association of State Public Health Veterinarians, Brown CM, Slavinski S, Ettestad P, Sidwa TJ, Sorghage FE. Compendium of animal rabies prevention and control, 2016. J. Am. Vet. Med. Assoc. 2016;248:505–517.
    doi: 10.2460/javma.248.5.505pubmed: 26885593google scholar: lookup
  44. Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J. Virol. 1998;72:3711–3719.
    doi: 10.1128/JVI.72.5.3711-3719.1998pmc: PMC109593pubmed: 9557653google scholar: lookup
  45. Wiktor T, Doherty P, Koprowski H. In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus. Proc. Natl. Acad. Sci. USA 1977;74:334–338.
    doi: 10.1073/pnas.74.1.334pmc: PMC393254pubmed: 299948google scholar: lookup
  46. Wiktor TJ, Doherty PC, Koprowski H. Suppression of cell-mediated immunity by street rabies virus. J. Exp. Med. 1977;145:1617–1622.
    doi: 10.1084/jem.145.6.1617pmc: PMC2180689pubmed: 301176google scholar: lookup
  47. Fischer L, Minke J, Dufay N, Baudu P, Audonnet J-C. Rabies DNA vaccine in the horse: Strategies to improve serological responses. Vaccine 2003;21:4593–4596.
    doi: 10.1016/S0264-410X(03)00504-8pubmed: 14575772google scholar: lookup
  48. Green S, Smith L, Vernau W, Beacock S. Rabies in horses: 21 cases (1970–1990). J. Am. Vet. Med. Assoc. 1992;200:1133–1137.
    pubmed: 1607322
  49. Chappuis G. Neonatal immunity and immunisation in early age: Lessons from veterinary medicine. Vaccine 1998;16:1468–1472.
    doi: 10.1016/S0264-410X(98)00110-8pmc: PMC7130764pubmed: 9711790google scholar: lookup
  50. Chapman GE, Baylis M, Archer D, Daly JM. The challenges posed by equine arboviruses. Equine Vet. J. 2018;50:436–445.
    doi: 10.1111/evj.12829pubmed: 29517814google scholar: lookup
  51. Chaintoutis SC, Diakakis N, Papanastassopoulou M, Banos G, Dovas CI. Evaluation of cross-protection of a lineage 1 West Nile virus inactivated vaccine against natural infections from a virulent lineage 2 strain in horses, under field conditions. Clin. Vaccine Immunol. 2015;22:1040–1049.
    doi: 10.1128/CVI.00302-15pmc: PMC4550672pubmed: 26178384google scholar: lookup
  52. Fehér O, Bakonyi T, Barna M, Nagy A, Takács M, Szenci O, Joó K, Sárdi S, Korbacska-Kutasi O. Serum neutralising antibody titres against a lineage 2 neuroinvasive West Nile Virus strain in response to vaccination with an inactivated lineage 1 vaccine in a European endemic area. Vet. Immunol. Immunopathol. 2020;227:110087.
    doi: 10.1016/j.vetimm.2020.110087pubmed: 32629300google scholar: lookup
  53. Minke J, Siger L, Cupillard L, Powers B, Bakonyi T, Boyum S, Nowotny N, Bowen R. Protection provided by a recombinant ALVAC®-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain. Vaccine 2011;29:4608–4612.
    doi: 10.1016/j.vaccine.2011.04.058pubmed: 21549780google scholar: lookup
  54. Waldridge BM, Wenzel J, Ellis A, Rowe-Morton SE, Bridges ER, D’Andrea G, Wint R. Serologic responses to eastern and western equine encephalomyelitis vaccination in previously vaccinated horses. Vet. Ther. Res. Appl. Vet. Med. 2003;4:242–248.
    pubmed: 15136985
  55. Gibbs EPJ, Wilson JH, All B. Studies on passive immunity and the vaccination of foals against eastern equine encephalitis in Florida. Proceedings of Equine Infectious Diseases V: Proceedings of the 5th International Conference. The University Press of Kentucky; Lexington, KY, USA: 1988; pp. 201–205.
  56. Calisher CH, Sasso DR, Sather GE. Possible evidence for interference with Venezuelan equine encephalitis virus vaccination of equines by pre-existing antibody to eastern or western equine encephalitis virus, or both. Appl. Microbiol. 1973;26:485–488.
    doi: 10.1128/am.26.4.485-488.1973pmc: PMC379832pubmed: 4751797google scholar: lookup
  57. Zacks MA, Paessler S. Encephalitic alphaviruses. Vet. Microbiol. 2010;140:281–286.
    doi: 10.1016/j.vetmic.2009.08.023pmc: PMC2814892pubmed: 19775836google scholar: lookup
  58. Walton T, Jochim M, Barber T, Thompson L. Cross-protective immunity between equine encephalomyelitis viruses in equids. Am. J. Vet. Res. 1989;50:1442–1446.
    pubmed: 2552875
  59. Barber T, Walton T, Lewis K. Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses. Am. J. Vet. Res. 1978;39:621–625.
    pubmed: 646197
  60. Ferguson J, Reeves WC, Hardy JL. Studies on immunity to alphaviruses in foals. Am. J. Vet. Res. 1979;40:5–10.
    pubmed: 453684
  61. Khatibzadeh SM, Gold CB, Keggan AE, Perkins GA, Glaser AL, Dubovi EJ, Wagner B. West Nile virus–specific immunoglobulin isotype responses in vaccinated and infected horses. Am. J. Vet. Res. 2015;76:92–100.
    doi: 10.2460/ajvr.76.1.92pmc: PMC10959050pubmed: 25535666google scholar: lookup
  62. Siger L, Bowen R, Karaca K, Murray M, Jagannatha S, Echols B, Nordgren R, Minke JM. Evaluation of the efficacy provided by a recombinant canarypox-vectored equine West Nile virus vaccine against an experimental West Nile virus intrathecal challenge in horses. Vet. Ther. 2006;7:249–256.
    pubmed: 17039448
  63. Long M, Gibbs E, Mellencamp M, Bowen R, Seino K, Zhang S, Beachboard S, Humphrey P. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model. Equine Vet. J. 2007;39:491–497.
    doi: 10.2746/042516407X217416pubmed: 18065305google scholar: lookup
  64. Siger L, Bowen RA, Karaca K, Murray MJ, Gordy PW, Loosmore SM, Audonnet J-CF, Nordgren RM, Minke JM. Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses. Am. J. Vet. Res. 2004;65:1459–1462.
    doi: 10.2460/ajvr.2004.65.1459pubmed: 15566080google scholar: lookup
  65. Davidson AH, Traub-Dargatz JL, Rodeheaver RM, Ostlund EN, Pedersen DD, Moorhead RG, Stricklin JB, Dewell RD, Roach SD, Long RE. Immunologic responses to West Nile virus in vaccinated and clinically affected horses. J. Am. Vet. Med. Assoc. 2005;226:240–245.
    doi: 10.2460/javma.2005.226.240pubmed: 15706975google scholar: lookup
  66. Ng T, Hathaway D, Jennings N, Champ D, Chiang Y, Chu H. Equine vaccine for West Nile virus. Dev. Biol. 2003;114:221–227.
    pubmed: 14677692
  67. Long MT, Jeter W, Hernandez J, Sellon DC, Gosche D, Gillis K, Bille E, Gibbs EP. Diagnostic performance of the equine IgM capture ELISA for serodiagnosis of West Nile virus infection. J. Vet. Intern. Med. 2006;20:608–613.
    doi: 10.1111/j.1939-1676.2006.tb02904.xpubmed: 16734097google scholar: lookup
  68. Long MT. West Nile virus and equine encephalitis viruses: New perspectives. Vet. Clin. Equine Pract. 2014;30:523–542.
    doi: 10.1016/j.cveq.2014.08.009pubmed: 25441112google scholar: lookup
  69. Long M, Porter M, Hernandez J, Giguere S, Fontaine G, Jodoin E, Gillis K. Preliminary data regarding the subclinical exposure rate of horses to West Nile virus during the 2001 Florida enzootic. Proc. Am. Assoc. Equine Pract. 2003;49:397–398.
  70. Durand B, Dauphin G, Zeller H, Labie J, Schuffenecker I, Murri S, Moutou F, Zientara S. Serosurvey for West Nile virus in horses in southern France. Vet. Rec. 2005;157:711.
    doi: 10.1136/vr.157.22.711pubmed: 16311385google scholar: lookup
  71. Roehrig JT, Nash D, Maldin B, Labowitz A, Martin DA, Lanciotti RS, Campbell GL. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg. Infect. Dis. 2003;9:376.
    doi: 10.3201/eid0903.020531pmc: PMC2958550pubmed: 12643836google scholar: lookup
  72. Kitai Y, Shirafuji H, Kanehira K, Kamio T, Kondo T, Konishi E. Specific antibody responses to West Nile virus infections in horses preimmunized with inactivated Japanese encephalitis vaccine: Evaluation of blocking enzyme-linked immunosorbent assay and complement-dependent cytotoxicity assay. Vector-Borne Zoonotic Dis. 2011;11:1093–1098.
    doi: 10.1089/vbz.2010.0094pubmed: 21254919google scholar: lookup
  73. Vest DJ, Cohen ND, Berezowski CJ, Morehead JP, Blodgett GP, Blanchard TL. Evaluation of administration of West Nile virus vaccine to pregnant broodmares. J. Am. Vet. Med. Assoc. 2004;225:1894–1897.
    doi: 10.2460/javma.2004.225.1894pubmed: 15643840google scholar: lookup
  74. Wilkins PA, Glaser AL, McDonnell SM. Passive transfer of naturally acquired specific immunity against West Nile Virus to foals in a semi-feral pony herd. J. Vet. Intern. Med. 2006;20:1045–1047.
    doi: 10.1111/j.1939-1676.2006.tb01828.xpubmed: 16955839google scholar: lookup
  75. Gardner IA, Wong SJ, Ferraro GL, Balasuriya UB, Hullinger PJ, Wilson WD, Shi P-Y, MacLachlan NJ. Incidence and effects of West Nile virus infection in vaccinated and unvaccinated horses in California. Vet. Res. 2007;38:109–116.
    doi: 10.1051/vetres:2006045pubmed: 17274156google scholar: lookup
  76. Boyle A, Timoney JF, Newton J, Hines M, Waller A, Buchanan B. Streptococcus equi infections in horses: Guidelines for treatment, control, and prevention of strangles—revised consensus statement. J. Vet. Intern. Med. 2018;32:633–647.
    doi: 10.1111/jvim.15043pmc: PMC5867011pubmed: 29424487google scholar: lookup
  77. Andersen SA, Petersen HH, Ersbøll AK, Falk-Rønne J, Jacobsen S. Vaccination elicits a prominent acute phase response in horses. Vet. J. 2012;191:199–202.
    doi: 10.1016/j.tvjl.2011.01.019pubmed: 21371917google scholar: lookup
  78. Arfuso F, Giudice E, Di Pietro S, Piccione G, Giannetto C. Modulation of Serum Protein Electrophoretic Pattern and Leukocyte Population in Horses Vaccinated against West Nile Virus. Animals 2021;11:477.
    doi: 10.3390/ani11020477pmc: PMC7918827pubmed: 33670395google scholar: lookup
  79. Holmes M, Townsend H, Hussey S, Breathnach C, Barnett C, Holland R, Lunn D. Immune responses to commercial equine vaccines. Proceedings of the 49th Annual Convention of the American Association of Equine Practitioners; New Orleans, LA, USA. 21–25 November 2003; pp. 224–226.
  80. Holmes MA, Townsend HG, Kohler AK, Hussey S, Breathnach C, Barnett C, Holland R, Lunn D. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus. Vet. Immunol. Immunopathol. 2006;111:67–80.
    doi: 10.1016/j.vetimm.2006.01.010pubmed: 16476488google scholar: lookup
  81. Cortese V, Hankins K, Holland R, Syvrud K. Serologic responses of West Nile virus seronegative mature horses to West Nile virus vaccines. J. Equine Vet. Sci. 2013;33:1101–1105.
    doi: 10.1016/j.jevs.2013.04.010google scholar: lookup
  82. Chapuis RJ, Smith JS, French HM, Toka FN, Peterson EW, Little EL. Nonlinear Mixed-Effect Pharmacokinetic Modeling and Distribution of Doxycycline in Healthy Female Donkeys after Multiple Intragastric Dosing–Preliminary Investigation. Animals 2021;11:2047.
    doi: 10.3390/ani11072047pmc: PMC8300337pubmed: 34359175google scholar: lookup
  83. Barrandeguy ME, Carossino M. Infectious diseases in donkeys and mules: An overview and update. J. Equine Vet. Sci. 2018;65:98–105.
    doi: 10.1016/j.jevs.2018.02.026google scholar: lookup
  84. Day M. The CALLISTO project: A summary. J. Comp. Pathol. 2016;155:S1–S7.
    doi: 10.1016/j.jcpa.2015.01.005pubmed: 25728814google scholar: lookup

Citations

This article has been cited 5 times.
  1. Bereda G. Co-infection of COVID-19 and pulmonary tuberculosis: a case report on lung and liver damage. Ann Med Surg (Lond) 2025 Apr;87(4):2346-2348.
    doi: 10.1097/MS9.0000000000000997pubmed: 40212164google scholar: lookup
  2. Gerras J, Young K, Roberts D, Waldman G, Salmon JH, Gilger BC. Uveitis and blindness in a closed herd of Equidae following leptospiral infection. Front Vet Sci 2024;11:1504990.
    doi: 10.3389/fvets.2024.1504990pubmed: 39834922google scholar: lookup
  3. Cendejas PM, Goodman AG. Vaccination and Control Methods of West Nile Virus Infection in Equids and Humans. Vaccines (Basel) 2024 May 1;12(5).
    doi: 10.3390/vaccines12050485pubmed: 38793736google scholar: lookup
  4. Kinoshita Y, Yamanaka T, Kodaira K, Niwa H, Uchida-Fujii E, Ueno T. Assessment of tetanus revaccination regimens in horses not vaccinated in the previous year. J Vet Med Sci 2023 Jul 17;85(7):751-754.
    doi: 10.1292/jvms.23-0158pubmed: 37258221google scholar: lookup
  5. Carnet F, Perrin-Cocon L, Paillot R, Lotteau V, Pronost S, Vidalain PO. An inventory of adjuvants used for vaccination in horses: the past, the present and the future. Vet Res 2023 Mar 2;54(1):18.
    doi: 10.1186/s13567-023-01151-3pubmed: 36864517google scholar: lookup
Subscribe to our newsletter
Join 99,316 horse owners like you who receive our email updates on horse health and nutrition.